Total Payments
$1,608
2024 Payments
$1,034
Companies
11
Transactions
113
Medicare Patients
2,560
Medicare Billing
$517,510
Payment Breakdown by Category
Food & Beverage$1,608 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,608 | 113 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $862.95 | 64 | $0 (2024) |
| Amgen Inc. | $271.93 | 23 | $0 (2024) |
| PFIZER INC. | $115.81 | 6 | $0 (2024) |
| Lilly USA, LLC | $69.54 | 4 | $0 (2024) |
| Janssen Biotech, Inc. | $68.92 | 4 | $0 (2024) |
| GlaxoSmithKline, LLC. | $67.55 | 4 | $0 (2024) |
| UCB, Inc. | $45.58 | 3 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $44.72 | 1 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $35.34 | 2 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $14.97 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,034 | 75 | ABBVIE INC. ($588.75) |
| 2023 | $488.58 | 34 | ABBVIE INC. ($274.20) |
| 2022 | $40.94 | 3 | GlaxoSmithKline, LLC. ($15.06) |
| 2019 | $44.72 | 1 | E.R. Squibb & Sons, L.L.C. ($44.72) |
All Payment Transactions
113 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $14.79 | General |
| Category: Bone Health | ||||||
| 12/17/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $6.22 | General |
| Category: IMMUNOLOGY | ||||||
| 12/11/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $19.89 | General |
| Category: IMMUNOLOGY | ||||||
| 12/06/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $13.67 | General |
| Category: IMMUNOLOGY | ||||||
| 12/05/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $14.28 | General |
| Category: Immunology | ||||||
| 12/03/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $10.29 | General |
| Category: Inflammation | ||||||
| 11/26/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $7.44 | General |
| Category: Inflammation | ||||||
| 11/22/2024 | ABBVIE INC. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $12.81 | General |
| Category: IMMUNOLOGY | ||||||
| 11/07/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $31.63 | General |
| Category: IMMUNOLOGY | ||||||
| 10/29/2024 | Amgen Inc. | — | Food and Beverage | In-kind items and services | $15.04 | General |
| 10/29/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $4.28 | General |
| Category: IMMUNOLOGY | ||||||
| 10/25/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $9.66 | General |
| Category: IMMUNOLOGY | ||||||
| 10/16/2024 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $22.69 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 10/15/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $6.94 | General |
| Category: Inflammation | ||||||
| 10/03/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $25.94 | General |
| Category: IMMUNOLOGY | ||||||
| 10/01/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $10.11 | General |
| Category: IMMUNOLOGY | ||||||
| 09/27/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $13.16 | General |
| Category: IMMUNOLOGY | ||||||
| 09/17/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $9.09 | General |
| Category: Inflammation | ||||||
| 09/12/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $13.88 | General |
| Category: IMMUNOLOGY | ||||||
| 09/10/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $34.47 | General |
| Category: IMMUNOLOGY | ||||||
| 09/03/2024 | Amgen Inc. | Enbrel (Biological) | Food and Beverage | In-kind items and services | $9.86 | General |
| Category: Inflammation | ||||||
| 08/29/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $8.12 | General |
| Category: Inflammation | ||||||
| 08/27/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $10.55 | General |
| Category: IMMUNOLOGY | ||||||
| 08/22/2024 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $22.69 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 08/22/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $18.73 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 41 | 1,798 | 33,357 | $1.6M | $458,021 |
| 2022 | 25 | 762 | 2,038 | $264,578 | $59,489 |
Total Patients
2,560
Total Services
35,395
Medicare Billing
$517,510
Procedure Codes
67
All Medicare Procedures & Services
67 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 2023 | 26 | 3,575 | $218,075 | $120,638 | 55.3% |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | Office | 2023 | 53 | 4,180 | $718,960 | $109,950 | 15.3% |
| J3262 | Injection, tocilizumab, 1 mg | Office | 2023 | 14 | 15,800 | $111,232 | $59,631 | 53.6% |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | Office | 2023 | 22 | 5,300 | $202,566 | $53,963 | 26.6% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 19 | 1,740 | $62,779 | $30,557 | 48.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 119 | 258 | $42,570 | $23,189 | 54.5% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 115 | 187 | $93,500 | $17,797 | 19.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 104 | 104 | $26,520 | $11,085 | 41.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 61 | 79 | $9,480 | $5,315 | 56.1% |
| 86235 | Measurement of antibody for assessment of autoimmune disorder, any method | Office | 2023 | 68 | 195 | $8,968 | $3,303 | 36.8% |
| 86480 | Tuberculosis test, gamma interferon | Office | 2023 | 51 | 54 | $8,316 | $3,280 | 39.4% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 135 | 205 | $5,867 | $2,111 | 36.0% |
| 73120 | X-ray of hand, 2 views | Office | 2023 | 45 | 90 | $4,415 | $2,020 | 45.7% |
| 96401 | Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 21 | 31 | $5,332 | $1,672 | 31.3% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 127 | 195 | $5,979 | $1,476 | 24.7% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 23 | 28 | $4,560 | $1,405 | 30.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 100 | 150 | $1,533 | $1,260 | 82.2% |
| 82306 | Vitamin d-3 level | Office | 2023 | 32 | 41 | $5,043 | $1,189 | 23.6% |
| 96415 | Administration of chemotherapy into vein, each additional hour | Office | 2023 | 23 | 45 | $5,400 | $951.30 | 17.6% |
| 86140 | Measurement c-reactive protein for detection of infection or inflammation | Office | 2023 | 108 | 163 | $5,332 | $822.96 | 15.4% |
| 73630 | X-ray of foot, minimum of 3 views | Office | 2023 | 17 | 34 | $1,870 | $684.98 | 36.6% |
| 72100 | X-ray of lower and sacral spine, 2-3 views | Office | 2023 | 20 | 21 | $1,545 | $601.00 | 38.9% |
| 86160 | Measurement of complement (immune system proteins), antigen, | Office | 2023 | 22 | 48 | $3,091 | $564.48 | 18.3% |
| 96375 | Injection of additional new drug or substance into vein | Office | 2023 | 19 | 41 | $3,143 | $474.37 | 15.1% |
| 73560 | X-ray of knee, 1-2 views | Office | 2023 | 12 | 20 | $1,145 | $463.14 | 40.5% |
About Meriah Moore
Meriah Moore is a Rheumatology healthcare provider based in Columbus, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/05/2016. The National Provider Identifier (NPI) number assigned to this provider is 1124482294.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Meriah Moore has received a total of $1,608 in payments from pharmaceutical and medical device companies, with $1,034 received in 2024. These payments were reported across 113 transactions from 11 companies. The most common payment nature is "Food and Beverage" ($1,608).
As a Medicare-enrolled provider, Moore has provided services to 2,560 Medicare beneficiaries, totaling 35,395 services with total Medicare billing of $517,510. Data is available for 2 years (2022–2023), covering 67 distinct procedure/service records.
Ad
Practice Information
- Specialty Rheumatology
- Other Specialties Rheumatology, Student in an Organized Health Care Education/Training Program
- Location Columbus, OH
- Active Since 04/05/2016
- Last Updated 08/26/2025
- Taxonomy Code 207RR0500X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1124482294
Products in Payments
- RINVOQ (Biological) $739.86
- Enbrel (Biological) $179.45
- XELJANZ (Drug) $115.81
- SKYRIZI (Biological) $102.76
- TALTZ (Drug) $69.54
- TREMFYA (Drug) $68.92
- BENLYSTA (Biological) $67.55
- TAVNEOS (Drug) $60.36
- ORENCIA (Biological) $44.72
- Cimzia (Drug) $31.30
- HUMIRA (Biological) $20.33
- ILARIS (Drug) $19.88
- COSENTYX (Drug) $15.46
- SAPHNELO (Biological) $14.97
- EVENITY (Biological) $14.79
- Bimzelx (Biological) $14.28
- KRYSTEXXA (Biological) $2.29
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Rheumatology Doctors in Columbus
Dr. Kevin Schlessel, M.d, M.D
Rheumatology — Payments: $95,178
Rheumatology $95,178
Sheryl Mascarenhas, Md, MD
Rheumatology — Payments: $15,611
Rheumatology $15,611
Heather Lake, Do, DO
Rheumatology — Payments: $13,921
Rheumatology $13,921
Dr. Matthew Mundwiler, Md, MD
Rheumatology — Payments: $12,782
Rheumatology $12,782
Marc Antonchak, M.d, M.D
Rheumatology — Payments: $10,574
Rheumatology $10,574
Navya Parsa, Md, MD
Rheumatology — Payments: $8,302
Rheumatology $8,302